ArticlePediatric research2026
Barriers and benefits of insulin pump use in minority children with type 1 diabetes.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThere are significant racial disparities in glycemic control and device uptake among Non-Hispanic Black (NHB) children with type 1 diabetes mellitus (T1D). Research on the barriers and benefits of insulin pump use in this population remains limited. This study explores patients' and parents' perspectives on insulin pumps.
methodsA survey was administered to adolescents ages 12-21 years or parents of patients <12 years old with T1D, and demographics and diabetes history were collected.
resultsSurveys from 41 patients with 30 (73.2%) completed by adolescents and 11 (26.8%) by parents were collected. The majority (92.6%) of participants identified as Black; 31.7% were insulin pump users, 43.9% were non-users, and 24.4% were former users. Barriers reported included body image (56.1%), pump failure (34.2%) and concerns about practicality of use (31.7%). Parents more frequently reported financial and educational barriers (36.4% vs. 10%, p = 0.047, 27.3% vs. 3.3%, p = 0.022). Benefits reported included convenience (78.1%) and improved glycemic control (61%). Participants with positive attitudes toward insulin pumps were more likely to report 0 barriers, while former pump users were less likely to report 0 barriers.
conclusionUnderstanding the patient-perceived barriers and benefits of pumps in minority children with T1D may support targeted strategies to increase device uptake. IMPACT: Understanding the barriers to insulin pump use, as perceived by Black children and adolescents with Type 1 diabetes and their families, is critically important for improving device adoption and glycemic control. This study contributes valuable insights to the literature by centering the patients and family perspective. Our findings have the potential to significantly enhance diabetes outcomes in this population by equipping pediatric endocrinologists with actionable information to address these barriers.
Identifiers
42032192What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.